Christopher Ashdown, PhD

Christopher P. Ashdown, PhD, is the CEO and co-founder of Lahara Bio, a medical device company developing low-intensity vibration as a novel, non-pharmacologic therapeutic platform for oncology and aging-related diseases. He is an MD-PhD candidate at Stony Brook University, where his doctoral research focused on mechanobiology and the use of mechanical signals to modulate immune function in the setting of cancer.

Through Lahara Bio, he is translating this academic work into clinically actionable technologies, with a focus on supportive cancer care and combatting age-related functional decline. His work sits at the intersection of biomedical engineering, immunology, and biotechnology commercialization.